重药控股：累计回购公司股份15406600股

Core Viewpoint - The company, Chongqing Pharmaceutical Holdings, announced a share buyback program, indicating a strategic move to enhance shareholder value and confidence in the company's future performance [2] Summary by Categories Share Buyback Details - As of October 31, 2025, the company has repurchased a total of 15,406,600 shares through a dedicated securities account via centralized bidding, which represents approximately 0.8915% of the company's total share capital [2]